Price target
305.770.000.00%
The 26 analysts offering 1 year price forecasts for 0HD2 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 33 analysts giving stock ratings to 0HD2 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0HD2 EPS for the last quarter is −0.87 USD despite the estimation of −0.92 USD. In the next quarter EPS is expected to reach −0.59 USD. Track more of ALNYLAM PHARMACEUTICALS INC COM USD0.01 financials and stay on top of what is up with the company.
In the next quarter ALNYLAM PHARMACEUTICALS INC COM USD0.01 revenue is expected to reach 579.59 M USD. Check out ALNYLAM PHARMACEUTICALS INC COM USD0.01 revenue and earnings and make informed decisions.
According to analysts, 0HD2 price target is 305.77 USD with a max estimate of 400.00 USD and a min estimate of 178.00 USD. Check if this forecast comes true in a year, meanwhile watch ALNYLAM PHARMACEUTICALS INC COM USD0.01 stock price chart and keep track of the current situation with 0HD2 news and stock market news.
We've gathered opinions of 33 analysts rating 0HD2 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.